One trial [45] reported the relationship between HT and immune function, and the results showed that HT was associated with a reduction in the proportion of CTLA4+ TEMRAs and CTLA+CD8+ TEMRAs, and increasing the absolute numbers of naive CD8T cells when compared to waiting list group. The gene discussed is CTLA4; the disease is hematocrit.